A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Non-Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
Adding Nimble advances Swoop’s position as the only integrated ecosystem built to connect patients and HCPs with the right information to improve health outcomes.
During an MM+M podcast, sponsored by Swoop, [email protected], SVP of sales, explained how custom audience segments can be activated across the media plan.
Ron Elwell, CEO and founder of Swoop is a proud recipient of MM+M’s Pinnacle Award for his work furthering real world data and ML/AI in health marketing.
Google will end app tracking on Android, negatively impacting marketing – health marketers can avoid this with real world data, a privacy-safe solution.
Apple is compelling health marketers to adopt privacy-safe, AI-generated digital audiences created from offline RWD instead of online clickstream data.